Your browser doesn't support javascript.
loading
The role of α-synuclein ubiquitination in its selectivity of degradation pathway / 实用医学杂志
The Journal of Practical Medicine ; (24): 1758-1762, 2015.
Article in Zh | WPRIM | ID: wpr-467618
Responsible library: WPRO
ABSTRACT
Objective To investigate SIAH′s role in α-synuclein degradation, formation of Lewy bodies and neuronal death. Methods Proliferative activity of PC12 cells was measures by MTT assay after treatment with MPP and Rapamycin. Western Blot was applied determine the protein expression of LC3-Ⅱ, E1, SIAH-1, P53 and α-synucleinto. PCR was applied to measure protein related mRNA levels. Immunofluorescent techniques were used to detect the distribution of α-synuclein, SIAH-1 and LC3 in cells after SIAH antibody processing. Results MPP+ treatment increased α-synuclein, E1 expression and SIAH-1 activity, however, LC3-Ⅱ, P53 and α-synuclein protein levels decreased significantly. Anti-SIAH-1 antibody treatment reversed this trend, with E1 significantly increased. Rapamycin treatment reduced SIAH-1 and α-synuclein levels in the MPP+ group. SIAH-1 antibody significantly decreased the positive immuno-stain of α-synuclein, SIAH-1 and LC3, suggesting loss of co-localization. Conclusions Anti-SIAH-1 supports the clearance of non-aggregated α-synuclein by the UPS. SIAH plays a key role in the pathogenesis of Parkinson′s disease and is a potential therapeutic target of neurodegenerative diseases.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: The Journal of Practical Medicine Year: 2015 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: The Journal of Practical Medicine Year: 2015 Type: Article